T&R Biofab Cash Flow Statement

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Net Income	-9,606	-7,679	-13,419
Depreciation & Amortization	4,023	2,404	2,156
Loss (Gain) From Sale of Assets	-67.39	5.8	0.14
Asset Writedown & Restructuring Costs	-	-	195.49
Loss (Gain) From Sale of Investments	-1,748	517.37	-5.26
Stock-Based Compensation	433.99	792.02	1,347
Provision & Write-off of Bad Debts	-241.86	792.12	542.03
Other Operating Activities	1,390	-5,237	2,105
Change in Accounts Receivable	-997.08	-531.04	-843.53
Change in Inventory	781.85	-612.32	361.88
Change in Accounts Payable	-179.56	-1,070	-1.18
Change in Unearned Revenue	-	46.9	-
Change in Other Net Operating Assets	-3,519	-1,162	597.43
Operating Cash Flow	-9,581	-11,733	-6,963
Capital Expenditures	-2,082	-2,576	-12,493
Cash Acquisitions	-6,453	-6,453	-
Sale (Purchase) of Intangibles	42.63	-232.19	-237.02
Investment in Securities	971.83	22,726	-25,002
Other Investing Activities	6,646	145.27	138.24
Investing Cash Flow	-2,771	11,689	-37,515
Long-Term Debt Issued	-	17,200	34,000
Long-Term Debt Repaid	-	-25,549	-6,478
Net Debt Issued (Repaid)	906.23	-8,349	27,522
Issuance of Common Stock	-	34.18	2,024
Other Financing Activities	-92.7	0	38.42
Financing Cash Flow	2,614	-3,515	29,585
Foreign Exchange Rate Adjustments	-22.51	2.43	-0.25
Miscellaneous Cash Flow Adjustments	0	0	-0
Net Cash Flow	-9,761	-3,556	-14,894
Free Cash Flow	-11,663	-14,309	-19,456
Free Cash Flow Margin	-56.41%	-293.60%	-374.22%
Free Cash Flow Per Share	-451.23	-553.57	-764.65
Cash Interest Paid	1,652	860.99	191.13
Cash Income Tax Paid	70.04	3.99	-14.54
Levered Free Cash Flow	-	-17,632	-
Unlevered Free Cash Flow	-	-17,631	-
Change in Working Capital	-3,765	-3,328	114.61

Source: S&P Global Market Intelligence. Standard template. Financial Sources.